It is not yet FDA-approved, but research peptide versions are available through specialized sources
According to Sara Talpos of the science magazine Undark , a company partly owned by Sikiric sponsored a 2015 trial, at a hospital in Tijuana, that tested the safety of an oral version of BPC-157
TB-500 (wound healing) TB-500 is listed as thymosin beta-4 fragment (LKKTETQ), evaluated for wound healing
Whether working with metabolic, longevity, cosmetic or performance-related research compounds, BAC Water remains an essential part of many laboratory protocols.
In other words, the liquid advantage is mostly about improving reliability and convenience for people whose pill absorption is compromised, not about delivering a stronger or fundamentally different result